Pharmaceuticals
WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus
SHANGHAI, Jan. 29, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, has stepped up its efforts in enabling the development of multipl...
Systech Deploys First Serialization Lines for Takeda Pharmaceutical International AG to Meet New Russian Regulations
PRINCETON, New Jersey, Jan. 28, 2020 /PRNewswire/ -- Systech, the global technology leader in brand protection and digital product authentication, announced today it has successfully upgraded serialization lines forTakeda to meet new Russian serialization regulations.October 1, 2019 was the first...
SunGen and Camber Announce U.S. Launch of Generic Version of Bentyl® (Dicyclomine) Injection
PRINCETON, New Jersey, Jan. 25, 2020 /PRNewswire/ -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced the U.S. launch and commercial shipment of generic version of Bentyl® (Dicycl...
CStone announces first patient dosed in the global proof-of-concept study of CS1001 in combination with Bayer's regorafenib
SUZHOU, China, Jan. 24, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) recently announced that it has dosed the first patient inAustralia in a clinical trial of CS1001, an investigational PD-L1 inhibitor developed by CStone, in combination with regorafenib, an...
CStone successfully hosted the first U.S. R&D Day in New York
* Among CStone's 15 cancer drug candidates, five candidates are in pivotal late-stage clinical development, with a total of 13 on-going registrational trials. * The Company has implemented its pipeline strategy for early-stage candidates and combination therapy. With an established clinical d...
CStone successfully hosted the first U.S. R&D Day in New York
* Among CStone's 15 cancer drug candidates, five candidates are in pivotal late-stage clinical development, with a total of 13 on-going registrational trials. * The Company has implemented its pipeline strategy for early-stage candidates and combination therapy. With an established clinical d...
Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus
PLYMOUTH MEETING, Pa., Jan. 24, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Inovio a grant of up to$9 million to develop a vaccine against the recently emerged strain of coronavirus (2019-nCo...
Week's Top Stories
Most Reposted
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
[Picked up by 337 media titles]
2025-01-18 03:30Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
[Picked up by 311 media titles]
2025-01-18 17:00Supported by the Luxembourg Government, The Luxembourg House of Financial Technology (LHoFT) and the Asian Development Bank (ADB) Announce the 2nd Edition of Catapult | SE Asia 2025
[Picked up by 310 media titles]
2025-01-22 15:38dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
[Picked up by 308 media titles]
2025-01-21 16:00HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
[Picked up by 306 media titles]
2025-01-20 14:27